Detalhe da pesquisa
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078508
2.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
3.
The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.
BMC Cancer
; 19(1): 471, 2019 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109313
4.
Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.
Am J Hematol
; 97(5): E168-E171, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108412
5.
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
Blood
; 123(16): 2513-7; quiz 2593, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449210
6.
An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial.
Ann Rheum Dis
; 74(6): 1195-201, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443001
7.
Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.
Ann Rheum Dis
; 74(9): 1734-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854586
8.
Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
Ann Rheum Dis
; 73(5): 909-12, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385201
9.
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
Br J Haematol
; 160(5): 640-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293871
10.
Reduced-dose rituximab in rheumatoid arthritis: efficacy depends on degree of B cell depletion.
Arthritis Rheum
; 63(3): 603-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21360489
11.
B cell biomarkers of rituximab responses in systemic lupus erythematosus.
Arthritis Rheum
; 63(10): 3038-47, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21618204
12.
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.
ACR Open Rheumatol
; 4(8): 689-699, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666029
13.
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.
BMJ Open
; 11(2): e041296, 2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619185
14.
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells.
Clin Cancer Res
; 27(20): 5647-5659, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380642
15.
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.
Leukemia
; 35(11): 3059-3072, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168283
16.
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.
Haematologica
; 100(3): e110-3, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480495
17.
Response to Dr Bredemeier's letter.
Ann Rheum Dis
; 73(6): e34, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24632007
18.
Telomere length predicts for outcome to FCR chemotherapy in CLL.
Leukemia
; 33(8): 1953-1963, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700843
19.
Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis.
Ann Rheum Dis
; 72(3): 463-4, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23144447
20.
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Leukemia
; 36(1): 271-274, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34148055